Intrepid Labs Valuation, Funding & Investors

Intrepid Labs is valued at $6.8B as of May 2025.

Last Intrepid Labs valuation

$6.8B

Seed · May 2025

Last Intrepid Labs funding round

$7M

Seed · May 2025

Cumulative funding Intrepid Labs raised

$11M

across 2 funding rounds

Key investors in Intrepid Labs

  • Radical Ventures
  • Propagator Ventures
  • Avant Bio

Intrepid Labs Overview

About Intrepid Labs

Intrepid Labs is a biotechnology firm spun out of the University of Toronto in 2022. The company applies artificial intelligence and robotics to automate drug formulation processes, speeding up therapeutic development for pharmaceuticals. Its platform optimizes solid oral dosage forms by predicting formulation outcomes and reducing trial-and-error iterations. Based in Toronto, Ontario, Intrepid Labs partners with contract development organizations to enhance efficiency in early-stage drug manufacturing pipelines.


Founded

2023

HQ

CanadaToronto

Status

Privately held

Customer focus

B2B

Revenue model

Services

Valuation

$6.8B (May 2025)

Intrepid Labs Valuation

Intrepid Labs is currently valued at $6.8B, based on its seed round in May 2025.

The $7M round was led by Avant Bio.

Intrepid Labs valuation by funding round

Intrepid Labs valuation by funding round
DateStageValuation
May 2025Seed$6.8B

Intrepid Labs Funding History

Intrepid Labs has raised a total of $11M across 2 funding rounds.

Intrepid Labs' first fundraising round was a $4M seed round in May 2024. The most recent completed round was a $7M seed round in May 2025.

Intrepid Labs funding rounds

Intrepid Labs funding rounds
DateStageInvestorsRaisedValuationDeal Summary
May 2025SeedAvant Bio (lead)$7M$6.8BIntrepid Labs is a Toronto-based biotechnology company founded in 2023 that develops next-generation drug products using its Valiant platform, which integrates machine learning, robotics, and pharmaceutical expertise to accelerate formulation design from months to days by exploring billions of possibilities. The platform enables zero-to-one learning without pre-existing data and multi-objective optimization for factors like solubility and manufacturability, targeting oral and long-acting injectable delivery for small molecules and biologics. It has secured partnerships with multiple pharmaceutical companies, contract research organizations, and biotechs. On May 12, 2025, Intrepid Labs raised $7 million in a seed round led by AVANT BIO, bringing total financing to over $11 million following a prior $4 million pre-seed led by Radical Ventures with Propagator Ventures. The round occurred at a $6.8 billion valuation. Proceeds fund team expansion, proprietary delivery technology development, and scaling commercial operations to meet partner demand. Post-round, Intrepid Labs formed a strategic partnership with Quotient Sciences to advance AI-guided formulation and launched in-house programs, underscoring its role in addressing formulation bottlenecks contributing to high clinical trial failure rates.
May 2024SeedRadical Ventures (lead); Propagator Ventures$4M-Intrepid Labs is a Toronto-based biotech company that emerged from the University of Toronto in 2023, developing the Valiant platform, which uses AI, machine learning, and robotics to accelerate drug formulation for small molecules and biologics, reducing timelines from months to days. The platform enables zero-to-one learning without pre-existing data and multi-objective optimization for factors like release kinetics and solubility. Intrepid has secured partnerships with top global pharmaceutical companies, including two of the top-10 and four of the top-20, plus CROs, and holds eight commercial agreements. It is advancing proprietary technologies like X-TEND for long-acting injectables and N-HANCE for oral bioavailability, available for licensing. Intrepid Labs raised a $4 million USD pre-seed round led by Radical Ventures with participation from Propagator Ventures, followed by a $7 million USD seed round led by Avant Bio, bringing total funding to $11 million USD. The funds support team expansion, technology development, scaling commercial operations, laboratory growth, and robotics infrastructure. The company is a resident at Johnson & Johnson Innovation – JLABS and part of the Vector Institute’s Fast-Lane Program.

Who has invested in Intrepid Labs?

3 investors have backed Intrepid Labs across its funding rounds, including Radical Ventures, Propagator Ventures and Avant Bio.

Lead investors include Avant Bio and Radical Ventures.


Intrepid Labs Investors

Investors in Intrepid Labs by funding rounds participated
InvestorHQRoundsRoleFirst check
Radical VenturesCanadaToronto1LeadMay 2024

This data is available for Pro users. Sign up to see all 3 Intrepid Labs investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Intrepid Labs Competitors

Intrepid Labs competitors include listed companies like Presight AI and BillionToOne, and private ones like Astromech, Chai Discovery, Automation Anywhere and Peregrine Technologies.

Public and private companies comparable to Intrepid Labs
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
AstromechUnited StatesUnited StatesPrivate--$3.8B-
Chai DiscoveryUnited StatesSan Francisco, CAPrivate$48M-$3.8B-
Automation AnywhereUnited StatesSan Jose, CAPrivate$243M-$6.8B-
Peregrine TechnologiesUnited StatesSan Francisco, CAPrivate$30M-$6.8B-
Presight AIUAEUAEPublicly listed$825M$214M$5.7B5.4x
BillionToOneUnited StatesUnited StatesPublicly listed$305M$12M$5.2B11.7x

Intrepid Labs Public Comps

Intrepid Labs is still privately-owned, but its public comps include Presight AI, BillionToOne, Adaptive Biotech, Demant, 10x Genomics, Bloomage BioTechnology, MiniMax Group, Affle 3i, Ncino and Bio-Techne.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Presight AI$825M$214M6.3x5.4x24.4x20.8x
BillionToOne$305M$12M15.8x11.7x401.1x75.4x
Adaptive Biotech$277M($39M)16.7x16.0x(117.9x)675.9x
Demant$3.5B$782M3.6x3.2x16.1x13.5x
10x Genomics$643M($16M)14.9x15.2x(591.7x)(160.9x)
Bloomage BioTechnology$626M$103M3.8x4.1x22.9x23.1x
MiniMax Group$79M($1.9B)131.8x-(5.5x)-
Affle 3i$282M$67M7.4x6.7x31.3x29.5x

This data is available for Pro users. Sign up to see all Intrepid Labs competitors and their valuation data.

Start Free Trial

Common questions about Intrepid Labs

When was Intrepid Labs founded?Intrepid Labs was founded in 2023.
Where is Intrepid Labs headquartered?Intrepid Labs is headquartered in Toronto, Canada.
Is Intrepid Labs publicly listed?No, Intrepid Labs is a private, VC-backed company.
What is Intrepid Labs' valuation?Intrepid Labs was last valued at $6.8B in its seed round in May 2025.
How much funding has Intrepid Labs raised?Intrepid Labs has raised $11M across 2 funding rounds.
What was Intrepid Labs' last funding round?Intrepid Labs' last funding round was a $7M seed round in May 2025, led by Avant Bio.
Who are Intrepid Labs' investors?Intrepid Labs' investors include Radical Ventures, Avant Bio and Propagator Ventures.
Which companies are comparable to Intrepid Labs?Companies comparable to Intrepid Labs include Astromech, Chai Discovery, Automation Anywhere, Peregrine Technologies, Presight AI and BillionToOne.

See companies similar to Intrepid Labs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial